Macroaxis: Personalized Investing
Simple Personalized Investing

SP 500   1,655   13.81  Index Moved Down -0.83%
BAX COV BDX BCR World Allocation Impulse Management Funds 
United States GSPC USD ...  |  Investing Themes


Processing
Processing. Please wait...

AtriCure insider: Andrew Lux

       

Andrew Lux - AtriCure Insider Profile

COO and VP

Dr. Andrew L. Lux, Ph.D., is Chief Operating Officer, Vice President of AtriCure, Inc., since January 16, 2012. Since 2010, Dr. Lux served as the Senior Vice President of Manufacturing and Operations for IntriMed Technologies, a startup business focused on contract manufacturing of implantable medical devices. From 2008 to 2010, Dr. Lux was the Vice President of Research and Development, Operations and Service for WaterHealth International, Inc., a business focused on the water purification/disinfections markets. From 2006 to 2008, Dr. Lux was the General Manager for Medtronic, Inc.?s spinal division in Warsaw, Indiana, where he was responsible for the United States based manufacturing organization providing spinal implant and orthopedic instrumentation products. Prior to 2006, Dr. Lux served in a variety of executive capacities for medical device organizations including Baxter Healthcare, Inc., Medtronic, Inc., Johnson & Johnson and General Electric Company.
Age: 59  COO Since 2012  Ph.D    
513-755-4100  http://www.atricure.com

Management Efficency

The company has return on total asset (ROA) of (10.22) % which means that it has lost $10.22 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (53.59) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 8.44 M in liabilities with Debt to Equity (D/E) ratio of 0.67 which is about average as compared to similar companies. AtriCure Inc has Current Ratio of 2.29 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.
    

Other Executives

David Drachman, CEO
Michael Carrel, CEO
Richard Johnston, Chairman, MBA
Michael Rogge, President
Michael Hooven, Director
Elizabeth Krell, Director, Ph.D
Robert White, Director, MBA
Mark Lanning, Director
Donald Harrison, Director
Karen Robards, Director, MBA
Mark Collar, Director
Andrew CPA, VP
Patricia Kennedy, VP
Stewart Strong, VP

Entity Summary

AtriCure, Inc., a medical device company, develops, manufactures, and sells cardiac surgical ablation systems designed to create precise lesions or scars in cardiac tissue. AtriCure Inc [ATRC] is traded on NASDAQ General Markets in USA. It is located in AtriCure, Inc.West Chester, OH and employs 230 people. Filter other
    
Specify Title
Indicate Tenure
Select Industry
Click to run this filter
 Run Equity Filter
Filter Other Insiders
 
    
    
ATRC United States Nasdaq
AtriCure Inc
Benchmark S&P 500
Currency: USD - US Dollar
Traded on NASDAQ General Markets
    
    
Chance of
Bankruptcy
Less
Than
3%
In The Next
Two Years
AtriCure Inc has less than 3.0 (%) percent chance of experiencing financial distress in the next 2 years of operations.
    
    

AtriCure price boundaries

    
April 25 2013
 7.73 
  
 7.70 
(0.03)  Macroaxis: -0.38809831824062413 Down   0.39%  
Lowest period price (30 days)
May 10 2013
 9.19 
  
 9.57 
0.38  Macroaxis: 4.13492927094669 Up   4.13%  
Highest period price (30 days)
    

Promote AtriCure and Andrew Lux

Follow AtriCure with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add AtriCure to your reader
 

Today Change

 thisGreen ATRC ATRC agains markets  1.67 % Macroaxis: change 1.67 Moved Up  
 
 United States Nasdaq   0.97 % Macroaxis: 0.97 Moved Up  
 
 United States SP 500   0.83 % Macroaxis: 0.83 Moved Down  
 
 United States NYSE   0.94 % Macroaxis: 0.94 Moved Down  
 
 United States Russel   1.65 % Macroaxis: change 1.65 Moved Down  
 

Stock Performance

Shares Outstanding20.9 M
Number of Shares Shorted440.71 K


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium